Insider holders · CIK 0001385508
OPIANT PHARMACEUTICALS, INC. · OPNT
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Michael SinclairExecutive Chairman | 148,870 | 30,000 | 178,870 | Mar 6, 2019 · 5:15 pm EST | Form 4/A |
| Geoffrey Wolf10% Owner | 124,500 | — | 124,500 | Apr 17, 2018 · 12:11 pm EDT | Form 4 |
| Roger CrystalChief Executive Officer | 8,475 | — | 8,475 | Jan 8, 2019 · 4:51 pm EST | Form 4 |
| David D O'TooleChief Financial Officer | 6,015 | — | 6,015 | Aug 14, 2018 · 4:04 pm EDT | Form 4 |
| Ann L. MacDougallDirector | 5,000 | — | 5,000 | Jun 5, 2018 · 4:07 pm EDT | Form 4 |
| Kevin PollackSee Remarks | 4,820 | — | 4,820 | Jan 17, 2017 · 9:54 am EST | Form 4 |
| Thomas T. ThomasDirector | 0 | — | 0 | May 18, 2018 · 4:56 pm EDT | Form 4 |
| Phil SkolnickChief Scientific Officer | 0 | — | 0 | Mar 4, 2019 · 4:33 pm EST | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.